Online Effects of Transcranial Direct Current Stimulation in Real Time on Human Prefrontal and Striatal Metabolites

Biological Psychiatry

Volumn 80, Issue 6, 2016, Pages 432-438

  Hone Blanchet, Antoine ^a   Edden, Richard A ^b,c   Fecteau, Shirley ^a,d  

^a CENTER FOR INTERDISCIPLINARY RESEARCH IN REHABILITATION AND SOCIAL INTEGRATION   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FM Kirby Research Center for Functional Brain Imaging   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Dorsolateral prefrontal cortex; Glx; Magnetic resonance spectroscopy; N acetylaspartate; Striatum; Transcranial direct current stimulation

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; AMINO ACID BRAIN LEVEL; ARTICLE; BRAIN METABOLISM; CONCENTRATION LOSS; CONTROLLED STUDY; CORPUS STRIATUM; CROSSOVER PROCEDURE; DORSOLATERAL PREFRONTAL CORTEX; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NECK PAIN; NERVE STIMULATOR; NEUROCHEMISTRY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; ONLINE SYSTEM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; SKIN TINGLING; STIMULUS RESPONSE; TRANSCRANIAL DIRECT CURRENT STIMULATION; YOUNG ADULT; ANALOGS AND DERIVATIVES; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PREFRONTAL CORTEX;

ADULT; ASPARTIC ACID; CORPUS STRIATUM; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; HEALTHY VOLUNTEERS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; TRANSCRANIAL DIRECT CURRENT STIMULATION; YOUNG ADULT;

EID: 84964666455     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.11.008     Document Type: Article

References (42)

1. 1 Nihonsugi, T., Ihara, A., Haruno, M., Selective increase of intention-based economic decisions by noninvasive brain stimulation to the dorsolateral prefrontal cortex. J Neurosci 35 (2015), 3412–3419.
2. 2 Metuki, N., Sela, T., Lavidor, M., Enhancing cognitive control components of insight problems solving by anodal tDCS of the left dorsolateral prefrontal cortex. Brain Stimul 5 (2012), 110–115.
3. 3 Zaehle, T., Sandmann, P., Thorne, J.D., Jäncke, L., Herrmann, C.S., Transcranial direct current stimulation of the prefrontal cortex modulates working memory performance: Combined behavioural and electrophysiological evidence. BMC Neurosci, 12, 2011, 2.
4. 4 Horvath, J.C., Forte, J.D., Carter, O., Evidence that transcranial direct current stimulation (tDCS) generates little-to-no reliable neurophysiologic effect beyond MEP amplitude modulation in healthy human subjects: A systematic review. Neuropsychologia 66 (2015), 213–236.
5. 5 Horvath, J.C., Forte, J.D., Carter, O., Quantitative review finds no evidence of cognitive effects in healthy populations from single-session transcranial direct current stimulation (tDCS). Brain Stimul 8 (2015), 535–550.
6. 6 Stagg, C.J., Best, J.G., Stephenson, M.C., O'Shea, J., Wylezinska, M., Kincses, Z.T., et al. Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci 29 (2009), 5202–5206.
7. 7 George, M.S., Aston-Jones, G., Noninvasive techniques for probing neurocircuitry and treating illness: Vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology 35 (2012), 301–316.
8. 8 Brunoni, A.R., Nitsche, M.A., Bolognini, N., Bikson, M., Wagner, T., Merabet, L., et al. Clinical research with transcranial direct current stimulation (tDCS): Challenges and future directions. Brain Stimul 5 (2012), 175–195.
9. 9 Brunoni, A.R., Valiengo, L., Baccaro, A., Zañao, T.A., de Oliveira, J.F., Goulart, A., et al. The sertraline vs electrical current therapy for treating depression clinical study. JAMA Psychiatry 70 (2013), 383–391.
10. 10 Loo, C., Alonzo, A., Martin, D., Mitchell, P.B., Galvez, V., Sachdev, P., Transcranial direct current stimulation for depression: 3-week, randomized, sham-controlled trial. Br J Psychiatry 200 (2012), 52–59.
11. 11 Brunelin, J., Mondino, M., Gassab, L., Haesebaert, F., Gaha, L., Suaud-Chagny, M.F., et al. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry 169 (2012), 719–724.
12. 12 Jansen, J.M., Daams, J.G., Koeter, M.W.J., Veltman, D.J., van den Brink, W., Goudriaan, A.E., Effects of non-invasive neurostimulation on craving: A meta-analysis. Neurosci Biobehav Rev 37 (2013), 2472–2480.
13. 13 Liebetanz, D., Nitsche, M.A., Tergau, F., Paulus, W., Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain 125 (2002), 2238–2247.
14. 14 Nitsche, M.A., Liebetanz, D., Schlitterlau, A., Henschkle, U., Fricke, K., Fromman, K., et al. GABAergic modulation of DC stimulation-induced motor cortex excitability shifts in humans. Eur J Neurosci 19 (2004), 2720–2726.
15. 15 Urenjak, J., Williams, S.R., Gadian, D.G., Noble, M., Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 (1993), 981–989.
16. 16 Moffett, J.R., Ross, B., Arun, P., Madhavarao, C.N., Namboodiri, A.M., N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog Neurobiol 81 (2007), 89–131.
17. 17 Kelley, A.E., Memory and addiction: Shared neural circuitry and molecular mechanisms. Neuron 44 (2004), 161–179.
18. 18 Gandiga, P.C., Hummel, F.C., Cohen, L., Transcranial DC stimulation (tDCS): A tool for double-blind sham-controlled clinical studies in brain stimulation. Clin Neurophysiol 117 (2006), 845–850.
19. 19 Nitsche, M., Paulus, W., Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 57 (2001), 1899–1901.
20. 20 Mescher, M., Merkle, H., Kirsch, J., Garwood, M., Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11 (1998), 266–272.
21. 21 Puts, N.A., Edden, R.A., In vivo magnetic resonance spectroscopy of GABA: A methodological review. Prog Nucl Magn Reson Spectrosc 60 (2012), 29–41.
22. 22 Mullins, P.G., McGonigle, D.J., O'Gorman, R.L., Puts, N.A., Vidyasagar, R., Evans, C.J., et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage 86 (2014), 43–52.
23. 23 Wilson, M., Reynolds, G., Kauppinen, R.A., Arvanatis, T.N., Peet, A.C., A constrained least-squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data. Magn Reson Med 65 (2011), 1–12.
24. 24 Edden, R.A., Puts, N.A., Harris, A.D., Barker, P.B., Evans, C.J., Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy spectra. J Magn Reson Imaging 40 (2013), 1445–1452.
25. 25 Harris, A.J., Puts, N.A., Edden, R.A., Tissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation and tissue relaxation. J Magn Reson Imaging 42 (2015), 1431–1440.
26. 26 Nitsche, M.A., Jaussi, W., Liebetanz, D., Lang, N., Tergau, F., Paulus, W., Consolidation of human motor cortical neuroplasticity by D-cycloserine. Neuropsychopharmacology 29 (2004), 1573–1578.
27. 27 Van der Graaf, M., In vivo magnetic resonance spectroscopy: Basic methodology and clinical applications. Eur Biophys J 39 (2010), 527–540.
28. 28 Gruber, S., Frey, R., Mlyranick, V., Stadlbauer, A., Heiden, A., Kasper, S., et al. Quantification of metabolic differences in the brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol 38 (2003), 403–410.
29. 29 Mondino, M., Brunelin, J., Poulet, E., N-acetyl-aspartate level is decreased in the prefrontal cortex in subjects at-risk for schizophrenia. Front Psychiatry 4 (2013), 1–6.
30. 30 Steen, R.G., Hamer, R.M., Lieberman, J.A., Measurements of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and meta-analysis. Neuropsychopharmacology 30 (2005), 1949–1962.
31. 31 Kronenberg, G., Ende, G., Alm, B., Deuschle, M., Heuser, I., Colla, M., Increased NAA and reduced choline levels in the anterior cingulum following chronic methyphenidate. Eur Arch Psychiatry Clin Neurosci 258 (2008), 446–450.
32. 32 Wiguna, T., Guerrero, A., Wibisono, S., Sastroasmoro, S., Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr rations in the prefrontal cortices on school-age children in Indonesia: a study using 1H resonance spectroscopy (MRS). Clin Neuropharmacol 35 (2012), 81–85.
33. 33 Ertugrul, A., Volkan-Salanci, B., Basar, K., Oguz, K.K., Demir, B., Ergun, E.L., et al. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response. Psychiatry Res 174 (2009), 121–129.
34. 34 Fregni, F., Potvin, K., Dasilva, D., Wang, X., Lenkinski, R.E., Freedman, S.D., Pascual-Leone, A., Clinical effects and brain metabolic correlates in non-invasive cortical neuromodulation for visceral pain. Eur J Pain 15 (2011), 53–60.
35. 35 Clarke, V.P., Coffman, B.A., Trumbo, M.C., Gasparovic, C., Transcranial direct current stimulation (tDCS) produces localized and specific alterations in neurochemistry: A 1H magnetic resonance spectroscopy study. Neurosci Lett 500 (2011), 67–71.
36. 36 Kalivas, P.W., Duffy, P., Barry, J., Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251 (1989), 378–387.
37. 37 Shepherd, G.M.G., Corticostriatal connectivity and its role in disease. Nat Rev Neurosci 14 (2013), 278–291.
38. 38 Koob, G., Volkow, N.D., Neurocircuitry of addiction. Neuropsychopharmacology 35 (2009), 217–238.
39. 39 Fornito, A., Zalesky, A., Pantelis, C., Bullmore, E.T., Schizophrenia, neuroimaging and connectomics. Neuroimage 4 (2012), 2296–2314.
40. 40 Foerde, K., Poldrack, R.A., Khan, B.J., Bookheimer, S.Y., Bilder, R.M., Guthrie, D., et al. Selective corticostriatal dysfunction in schizophrenia: Examination of motor and cognitive skill learning. Neuropsychology 22 (2008), 100–109.
41. 41 Hasler, G., van der Veen, J.W., Tumonis, T., Meyers, N., Shen, J., Drevets, W.C., Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64 (2007), 193–200.
42. 42 Abdallah, C.G., Jiang, L., De Feyter, H.M., Fasula, M., Krystal, J.H., Rothman, D.L., et al. Glutamate metabolism in major depressive disorder. Am J Psychiatry 171 (2014), 1320–1327.